Hologic (HOLX) Wins Appeal on Patent Validity for SenoRx Case; Invalid Ruling Reversed
Tweet Send to a FriendGet Alerts HOLX Hot Sheet
Down)
Trade HOLX Now!
Bloomberg reporting that Hologic (Nasdaq: HOLX) has won an appeal on patent validity in its SenoRx case.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Intuitive Surgical (ISRG) Jury Reaches Positive Verdict in Robot Case; Shares Rise
- Microsoft's (MSFT) WP8 YouTube App Now Google (GOOG) Compliant
- Major ResCap Creditor MBIA (MBI) Trades Higher on Ally Settlement
Create E-mail Alert Related Categories
Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
